Status:
TERMINATED
Insulin Therapy in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
Lead Sponsor:
The Royal Bournemouth Hospital
Collaborating Sponsors:
Sanofi
Conditions:
Chronic Obstructive Pulmonary Disease
Hyperglycemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine the effect of preventing hyperglycaemia in patients admitted to hospital with acute exacerbations of chronic pulmonary disease.
Detailed Description
Hyperglycaemia is associated with increased morbidity and mortality in patients admitted to hospital with acute critical illness, myocardial infarction and stroke. Moreover patients with hyperglycaemi...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Patients who are NOT diabetic, admitted with COPD who are likely to be prescribed corticosteroids as part of usual care with an admission glucose level (before steroids) between 6.1 and 11.1 mmol/l.
- Exclusion criteria:
- Patients with diabetes mellitus
- Patients who are nil by mouth.
- Patients with severe co-morbid disease with an anticipated life expectancy of \< 6 months.
- Patients who are unable to provide informed consent.
- Age \<18 years.
Exclusion
Key Trial Info
Start Date :
July 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT00467636
Start Date
July 1 2007
End Date
May 1 2009
Last Update
October 2 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Bournemouth Hospital
Bournemouth, Dorset, United Kingdom, BH7 7DW